Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,264,156
+$26,427,934 QoQ
Shares Held
383,179
+181.6% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Mar 31, 2024CallValue
$805,750
CallShares
25,000
PutValue
$805,750
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,076,655 across 360 Biotechnology names. RVMD ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
This page
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in RVMD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,264,156 | 383,179 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,836,222 | 136,048 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,563,967 | 290,449 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $9,432,365 | 256,384 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $9,846,026 | 278,451 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $17,872,775 | 408,614 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $13,363,012 | 294,664 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $3,983,574 | 102,643 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $4,364,456 | 135,416 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $805,750 | 25,000 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $805,750 | 25,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $10,146,552 | 353,785 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $6,329,335 | 228,661 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $4,984,193 | 186,325 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $3,204,573 | 147,949 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $3,382,414 | 141,999 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $3,350,762 | 169,917 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $597,582 | 30,661 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $962,057 | 37,713 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||